BRICSS Cardiac Resynchronization Therapy (CRT) Devices Market Value is Expected to Reach US$455 Million by 2016

Date: 2015-06-11

BRICSS (Brazil, Russia, India, China, South Africa and South Korea) Cardiac Resynchronization Therapy (CRT) Devices sector to worth US$455 million by 2016, growing at a CAGR of 12.2% during 2012-2018
Global Market Watch:
BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types – Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Cardiac Resynchronization Pacemakers (CRT-P). China accounts for nearly 25% of the market share and India claims more than 23%. In terms of CAGR, China is the fastest growing region while India and South Korea are just behind. Among the product types, Cardiac Resynchronization Therapy Defibrillator (CRT-D) accounts more nearly half of the market value while Cardiac Resynchronization Pacemakers (CRT-P) segments add up to the remaining half.
Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.
Report Focus:
The report ‘Cardiac Resynchronization Therapy (CRT) Devices – Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018’ reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments.The study reveals profitable investment strategies for market start-ups,pharmaceutical/biotechnology companies, laboratories,Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyersand many more in preferred locations. The report primarily focuses on:
• Emerging Market Trends
• Advancements in the Technological Space
• Market Demand of The Segments (By-Region)
• Key Growth Areas and Market Size
• Region-Wise Demand Factor
• Key Competitors Edge
• Investment Strategies
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.
The analysis primarily deals with by type. Further, the subdivided categories include:
Cardiac Resynchronization Therapy (CRT) Devices – By Type
a. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
b. Cardiac Resynchronization Pacemakers (CRT-P)

The period considered for the cardiac resynchronization therapy (CRT) devices market analysis is 2012-2018. The region wise distribution of the market consists of BRICSS (Brazil,Russia, India, China, South Korea and South Africa).
More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 103 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample